- Home
- SLXN vs IMG Comparison
SLXN vs IMG Comparison
Compare SLXN & IMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXN
- IMG
- Stock Information
- Founded
- SLXN 2008
- IMG 2011
- Country
- SLXN Israel
- IMG United States
- Employees
- SLXN N/A
- IMG N/A
- Industry
- SLXN
- IMG
- Sector
- SLXN
- IMG
- Exchange
- SLXN NYSE
- IMG NYSE
- Market Cap
- SLXN 6.9M
- IMG 7.2M
- IPO Year
- SLXN N/A
- IMG 2020
- Fundamental
- Price
- SLXN $0.93
- IMG $0.64
- Analyst Decision
- SLXN Strong Buy
- IMG
- Analyst Count
- SLXN 1
- IMG 0
- Target Price
- SLXN $5.00
- IMG N/A
- AVG Volume (30 Days)
- SLXN 3.6M
- IMG 634.2K
- Earning Date
- SLXN 05-21-2025
- IMG 05-27-2025
- Dividend Yield
- SLXN N/A
- IMG N/A
- EPS Growth
- SLXN N/A
- IMG N/A
- EPS
- SLXN N/A
- IMG N/A
- Revenue
- SLXN N/A
- IMG $3,785,663.00
- Revenue This Year
- SLXN N/A
- IMG $99.05
- Revenue Next Year
- SLXN N/A
- IMG $130.30
- P/E Ratio
- SLXN N/A
- IMG N/A
- Revenue Growth
- SLXN N/A
- IMG 109.62
- 52 Week Low
- SLXN $0.21
- IMG $0.25
- 52 Week High
- SLXN $13.56
- IMG $8.00
- Technical
- Relative Strength Index (RSI)
- SLXN N/A
- IMG N/A
- Support Level
- SLXN N/A
- IMG N/A
- Resistance Level
- SLXN N/A
- IMG N/A
- Average True Range (ATR)
- SLXN 0.00
- IMG 0.00
- MACD
- SLXN 0.00
- IMG 0.00
- Stochastic Oscillator
- SLXN 0.00
- IMG 0.00
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.
About IMG CIMG INC
CIMG Inc is a coffee and technologies company. The company is a co-packer of single-serve pour-over coffee, coffee brew bags and Dripkits. The company's brand portfolio includes Coffee Blenders, Twin Peaks, Active Cup, Relax Cup, Think Cup, Nude Cup, Pine Ranch Coffee, and Dripkit. Its geographical segments are North America, which accounts for the majority of revenue; and South Korea.